Sentence examples for monitoring owing to from inspiring English sources

Kernel principal component analysis (KPCA) has become a popular technique for process monitoring, owing to its capability of handling nonlinearity.

Surface-enhanced Raman scattering (SERS) has been considered as a powerful analytic technology with wide applications in biomedical sensing, chemical analysis, and environmental monitoring owing to its extremely high sensitivity [1].

Hydromorphone has been found to be safe and effective in patients with impaired renal or hepatic function, although it is advised to be used with caution and close monitoring owing to the increased exposure to (mean Cmax and AUC were 2- to 4-fold higher) and slower elimination of hydromorphone and its metabolites in these patients [ 25- 29].

More than half of these (n=85) voluntarily stopped their licences during monitoring owing to factors such as advanced age, financial problems, or psychiatric or other health problems.

Immunogenicity was closely monitored owing to the possible appearance of neutralizing antibodies or the development of immediate hypersensitivity reactions.

Fluorescence imaging has become a powerful and popular tool in monitoring bio-species owing to their high sensitivity and selectivity, excellent spatiotemporal resolution and non-invasion nature.

Furthermore, making firms more transparent is also in the interests of the government as it is likely to be an ineffective monitor of managers, owing to capability and incentive problems.

Conventional MRI is the preferred imaging modality for the diagnosis, staging and monitoring of nasopharyngeal tumours owing to its superior soft tissue contrast resolution.

However, VKA treatment involves regular monitoring and dose adjustment, owing to a narrow therapeutic window and an inherent variability arising from genetic and dietary factors.

Several studies have evaluated whether these classical CSF biomarkers could also be used as markers to monitor progression of AD pathology in affected individuals but, to date, their levels have not been shown to be optimal markers for (therapeutic) monitoring in longitudinal studies owing to their relative stability in the later clinical stages of AD [ 6, 10, 14, 22, 33, 44, 48].

In a review of cardiovascular data from 180 patients with MS receiving a first dose of fingolimod in Brazil [ 53], a total of 12 (6.7%) patients required extended monitoring beyond 6 h owing to symptomatic bradycardia, whereas in clinical trials symptomatic bradycardia was reported by 0.6% of patients.